Какова цена за Entia Biosciences, Inc. (ERGO)

Цена за Entia Biosciences, Inc. (ERGO) Это $0.0002

Какова рыночная капитализация для Entia Biosciences, Inc. (ERGO)

Рыночная капитализация для Entia Biosciences, Inc. (ERGO) Это $6.73K

Entia Biosciences, Inc. (ERGO) Дивидендная доходность

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Год	Дивидендная доходность	Изменить
Недостаточно данных для указанных дат.

Год

Дивидендная доходность

Изменить

Недостаточно данных для указанных дат.

Компания	Дивидендная доходность	Страна
Royalty Pharma plc RPRX.US	1.56%	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	SE
Ipsen S.A. IPN.PA	0.00%	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	IT
Corcept Therapeutics Incorporated CORT.US	0.00%	US

Компания

Дивидендная доходность

Страна